Interest in enterprise imaging and its meaningful use technology platforms contributed to revenue growth for Merge Healthcare in its third quarter.
For the period (end-September 30), Merge had revenue of $60.1 million, up 33% from the $45.2 million reported in the third quarter of 2010. The vendor had a quarterly net loss of $1 million, compared with a net loss of $5 million a year ago.
Merge had adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) of $14.5 million, compared with EBITDA of $13 million in the third quarter last year. The company provided 2012 guidance of a pro forma revenue range of $288 million to $300 million with an adjusted EBITDA range of 22% to 24%.
